Core-shell magnetic nanoparticle carrier for targeted drug delivery: Challenges and design

Materials Technology

Volumn 25, Issue 3-4, 2010, Pages 118-126

  Misra, R D K ^a  

^a UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

Author keywords

MAGNETIC NANOCARRIER; NANOPARTICLES; STIMULI RESPONSE POLYMER; TARGETED DRUG DELIVERY

Indexed keywords

ANTICANCER DRUG; CONTROLLED RELEASE; CORE-SHELL; DELIVERY PROCESS; EXTERNAL MAGNETIC FIELD; MAGNETIC NANOCARRIERS; MAGNETIC NANOPARTICLES; NANOCARRIERS; PH SENSITIVITY; PH-RESPONSIVE; STIMULI-RESPONSE POLYMER; TARGETED DRUG DELIVERY; TUMOR CELLS; TUMOR SITE; TUMOR TARGETING;

DRUG DELIVERY; MAGNETIC FIELDS; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; RESONANCE; TUMORS;

NANOMAGNETICS;

EID: 77955973135     PISSN: 10667857     EISSN: None     Source Type: Journal    
DOI: 10.1179/175355510X12723642365241     Document Type: Article

References (40)

1. H. Gu, K. Yu, Z. Yang, C. K. Chang and B. Yu: 'Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles: a potential candidate for bimodal anticancer therapy', Chem. Commun., 2005, 34, 4270.
2. M. R. Detty, S. L. Gibson and S. J. Wagner: 'Current clinical and preclinical photosensitizers for use in photodynamic therapy', J. Med. Chem., 2004, 47, 3897.
3. A. Jordan, R. Scholz, P. Wust, H. Fahling and R. Felix: 'Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles', J. Magn. Magn. Mater., 1999, 201, 413.
4. G. Orive, R. M. Hernandez, A. R. Gascon, A. Dominguez-Gil and J. L. Pedraz: 'Drug delivery in biotechnology: present and future', Curr. Opin. Biotechol., 2003, 14, 659.
5. J. L. Zhang, R. S. Srivastava and R. D. K. Misra: 'Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization and lcst of viable drug-targeting delivery system', Langmuir, 2007, 23, 6342.
6. S. Rana, A. Gallo, R. S. Srivastava and R. D. K. Misra: 'On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: Functionalization, conjugation, and drug release kinetics', Acta Biomater., 2007, 3, 233.
7. S. D. Weitman, R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. Zurawski and B. A. Kamen: 'distribution of the folate receptor Gp38 in normal and malignant-cell lines and tissues', Cancer Res., 1992,52, 3396.
8. A. C. Antony: 'Folate receptors', Annu. Rev. Nutr., 1996, 16, 501.
9. Y. Lu and P. S. Low: 'Folate-mediated delivery of macromolecular anticancer therapeutic agents', Adv. Drug Deliv. Rev., 2002, 54, 675.
10. K. M. Maziarz, H. L. Monaco, F. Shen and M. Ratnam: 'Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta', J. Biol. Chem., 1999, 274, 11086.
11. A. D. Grief and G. Richardson: 'Mathematical modelling of magnetically targeted drug delivery', J. Magn. Magn. Mater., 2005, 293, 455.
12. S. Giri, B. G. Trewyn, M. P. Stellmaker and V. S.-Y. Lin: 'Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles', Angew. Chem. Int. Ed., 2005, 44, 5038.
13. T. Y. Liu, S. H. Hu, T. Y. Liu, D. M. Liu and S. Y. Chen: 'Magnetic-sensitive behavior of intelligent ferrogels for controlled release of drug', Langmuir, 2006, 22, 5974.
14. K. S. Soppimath, T. M. Aminabhavi, A. M. Dave, S. G. Kumbar and W. E. Rudzinski: 'Stimulus-responsive ''smart'' hydrogels as novel drug delivery systems', Drug Dev. Ind. Pharm., 2002, 28, 957.
15. Y. Qiu and K. Park: 'Enviroment-sensitive hydrogels for drug delivery', Adv. Drug Deliv. Rev., 2001, 53, 321.
16. K. M. Huh, Y. Kumashiro, T. Ooya and N. Yui: 'New synthetic route for dextran graft copolymers containing thermo-responsive polymers', Polym. J., 2001, 33, 108.
17. V. Y. Grinberg, N. V. Gronberg, A. I. Usov, N. P. Shusharina, A. R. Khokhlov and K. G. de Kruif: 'Thermodynamics of conformational ordering of -carrageenan in KCl solutions Using high-sensitivity differential scanning calorimetry', Biomacromolecules, 2001, 2, 874.
18. C. D. I. H Alarcon, S. Pennadam and C. Alexander: 'Stimuli responsive polymers for biomedical applications', Chem. Soc. Rev., 2005, 34, 276.
19. J. Wu, Z. G. Su and G. H. Ma: 'A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate', Int. J. Pharm., 2006, 315, 1.
20. S. Rana, J. Rawat, M. M. Sorensson and R. D. K. Misra: 'Antimicrobial function of Nd3z-doped anatase titania-coated nickel ferrite composite nanoparticles: a biomaterial system', Acta Biomater., 2006, 2, 421.
21. S. Rana, J. Rawat and R. D. K. Misra: 'Anti-microbial active composite nanoparticles with magnetic core and photocatalytic shell: TiO2-NiFe2O4 bio-material system', Acta Biomater., 2005, 1, 691.
22. H. Nathani, S. Gubbala and R. D. K. Misra: 'Magnetic behavior of nanocrystalline nickel ferrite: Part I. The effect of surface roughness', Mater. Sci. Eng. B, 2005, B121, 126.
23. R. D. K. Misra, S. Gubbala, A. Kale and W. F. Egelhoff, Jr: 'A comparison of the magnetic characteristics of nanocrystalline nickel, zinc, and manganese ferrites synthesized by reverse micelle technique', Mater. Sci. Eng. B, 2004, B111, 164.
24. S. Gubbala, H. Nathani, K. Koizol and R. D. K. Misra: 'Magnetic properties of nanocrystalline Ni-Zn, Zn-Mn, and Ni-Mn ferrites synthesized by reverse micelle technique', Physica B, 2004, 348B, 317.
25. A. Kale, S. Gubbala and R. D. K. Misra: 'Magnetic behavior of nanocrystalline nickel ferrite synthesized by the reverse micelle technique', J. Magn. Magn. Mater., 2004, 277, 350.
26. J. L. Zhang, S. Rana, R. S. Srivastava and R. D. K. Misra: 'On the chemical synthesis and drug delivery response of folate-receptor-activated, polyethylene glycol-functionalized magnetite nanoparti-cles', Acta Biomater., 2008, 4, 40.
27. A. K. Gupta and S. Wells: 'Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxity studies', IEEE Trans. Nanobiosci., 2005, 41, 4137.
28. T. Etrych, M. Jelinkova, B. Ri'hova and K. Ulbrich: 'New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties', J. Controll. Release, 2001, 73, 89.
29. R. J. Christie and D. W. Grainger: 'Design strategies to improve soluble macromolecular delivery constructs', Adv. Drug Deliv. Rev., 2003, 55, 421.
30. D. Willner, P. A. Trail, S. J. Hofstead, H. D. King, S. J. Lasch, G. R. Braslawsky, R. S. Greenfield, T. Kaneko and R. A. Firestone: '(6-Maleimidocaproyl)hydrazoneof doxorubicin-A new derivative for the preparation of immunoconjugates of doxorubi-cin', Bioconjug. Chem. , 1993, 4, 521.
31. R. A. Firestone, D. Willner, S. J. Hofstead, H. D. King, T. Kaneko, G. R. Braslawsky, R. S. Greenfield, P. A. Trail, S. J. Lasch, A. J. Henderson, A. M. Casazza, I. Hellstrom and K. E. Hellstrom: 'Synthesis and antitumor activity of the immunoconju-gate BR96-Dox', J. Controll. Release, 1996, 39, 251-259.
32. P. A. Trail, D. Willner, J. Knipe, A. J. Henderson, S. J. Lasch, M. E. Zoeckler, M. D. TrailSmith, T. W. Doyle, H. D. King, A. M. Casazza, G. R. Braslawsky, J. Brown, S. J. Hofstead, R. S. Greenfield, R. A. Firestone, K. Mosure, K. F. Kadow, M. B. Yang, K. E. Hellstrom and I. Hellstrom: 'Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates', Cancer Res., 1997, 57, 100.
33. H. D. King, D. Yurgaitis, D. Willner, R. A. Firestone, M. B. Yang, S. J. Lasch, K. E. Hellstrom and P. A. Trail: 'Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconju-gates', Bioconjug. Chem., 1999, 10, 279.
34. J. Zhang and R. D. K. Misra: 'Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nano-particle carrier and drug release response', Acta Biomater., 2007,3, 838.
35. E. Roux, M. Lafleur, E. Lataste, P. Moreau and J.-C. Leroux, 'On the characterization of pH-sensitive liposome/polymer complexes', Biomacromolecules, 2003, 4, 240.
36. U. O. Hafeli: 'Magnetically modulated therapeutic systems', Int. J. Pharm., 2004, 277, 19.
37. K. Kono: 'Thermosensitive polymer-modified liposomes', Adv. Drug Deliv. Rev., 2001, 53, 307.
38. Y. Z. You, C. Y. Hong, C. Y. Pan and P. H. Wang: 'Synthesis of a Dendritic Core-Shell Nanostructure with a Temperature-Sensitive Shell', Adv. Mater., 2004, 16, 1953.
39. D. Needham and M. W. Dewhirst: 'The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors', Adv. Drug Deliv. Rev., 2001, 53, 285.
40. C. Lemarchand, R. Gref and P. Couvreur: 'Polysaccharide-decorated nanoparticles', Eur. J. Pharm. Biopharm. , 2004, 58, 327.